v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
OPERATING EXPENSES        
General and administrative $ 2,739,021 $ 1,914,368 $ 5,293,701 $ 2,336,378
Research and development 1,616,009 33,126 2,843,695 38,002
Research and development expense- license acquired 0 0   1,046,965
TOTAL OPERATING EXPENSES 4,355,030 1,947,494 8,137,396 3,421,345
LOSS FROM OPERATIONS (4,355,030) (1,947,494) (8,137,396) (3,421,345)
OTHER INCOME (EXPENSE)        
Interest expense (342) (43,614) (1,653) (58,251)
Change in fair value of warrant liabilities 69,944 (38,702) (624,190) (38,702)
Loss on disposal of fixed asset 0 0 (3,230) 0
Equity in losses on equity method investment (92,842) 0 (117,351) 0
Total other expense, net (23,240) (82,316) (746,424) (96,953)
NET LOSS $ (4,378,270) $ (2,029,810) $ (8,883,820) $ (3,518,298)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.26) $ (0.33) $ (0.52) $ (0.59)
WEIGHTED AVERAGE SHARES OUTSTANDING:        
BASIC AND DILUTED 17,075,875 6,074,600 17,073,765 5,967,807

Source